Holen Sie sich die Stockscreener-App
46.49
0.92%
-0.43
Handel nachbörslich:
46.28
-0.21
-0.45%
Schlusskurs vom Vortag:
$46.92
Offen:
$46.73
24-Stunden-Volumen:
692.41K
Relative Volume:
0.61
Marktkapitalisierung:
$342.04M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-121.02M
KGV:
-4.1288
EPS:
-11.26
Netto-Cashflow:
$-114.09M
1W Leistung:
+19.17%
1M Leistung:
+30.74%
6M Leistung:
+275.22%
1J Leistung:
-3.15%
1-Tages-Spanne:
$44.10
$47.18
1-Wochen-Bereich:
$40.43
$48.50
52-Wochen-Spanne:
$7.31
$130.00
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Firmenname
Tonix Pharmaceuticals Holding Corp
Sektor
Branche
Telefon
212-980-9155
Adresse
26 MAIN STREET, SUITE 101, CHATHAM, NY
Vergleichen Sie TNXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
46.49 | 335.64M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-04-18 | Eingeleitet | Noble Capital Markets | Outperform |
| 2019-04-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2017-08-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2016-09-07 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-02-17 | Bestätigt | Oppenheimer | Outperform |
| 2015-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-12 | Eingeleitet | Oppenheimer | Outperform |
| 2015-02-17 | Bestätigt | ROTH Capital | Buy |
| 2014-09-29 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
Clinical Progress in Rare Disease Signals Long-Term Revenue Potential for Innovators - Benzinga
Tonix Pharmaceuticals Innovation: What’s Next? - timothysykes.com
TNXP’s Race Against Time: Market Buzz Remains High - StocksToTrade
Tonix Pharmaceuticals Holding Corp. Added to Custom Quant Screener TodayMarket Entry and Exit Point Tips From Traders - metal.it
Published on: 2025-08-04 09:31:49 - metal.it
What institutional investors are buying Tonix Pharmaceuticals Holding Corp. stockInvest confidently with professional market insights - Jammu Links News
How does Tonix Pharmaceuticals Holding Corp. compare to its industry peersOutstanding growth strategies - Jammu Links News
When is Tonix Pharmaceuticals Holding Corp. stock expected to show significant growthFree AI-Backed Trading Signals - Jammu Links News
How strong is Tonix Pharmaceuticals Holding Corp. company’s balance sheetCapitalize on high-yield stocks early - Jammu Links News
Should I hold or sell Tonix Pharmaceuticals Holding Corp. stock in 2025Phenomenal wealth increase - Jammu Links News
Is Tonix Pharmaceuticals Holding Corp. a growth stock or a value stockUnprecedented growth rates - Jammu Links News
Published on: 2025-08-03 07:26:37 - Jammu Links News
Does Tonix Pharmaceuticals Holding Corp. stock perform well during market downturnsDynamic profit opportunities - Jammu Links News
How volatile is Tonix Pharmaceuticals Holding Corp. stock compared to the marketUnlock high-yield investment opportunities - Jammu Links News
Why is Tonix Pharmaceuticals Holding Corp. stock attracting strong analyst attentionWealth Building Opportunities For Beginners - Jammu Links News
What are the technical indicators suggesting about Tonix Pharmaceuticals Holding Corp.Chart Pattern Report Backed By Experts - Jammu Links News
Key resistance and support levels for Tonix Pharmaceuticals Holding Corp.Early Entry Picks Before News Breakout Reviewed - metal.it
Tonix launches Move Fibro Forward campaign to support millions living with Fibromyalgia - Proactive financial news
Price Channel Expanding on Tonix Pharmaceuticals Holding Corp.’s ChartLow Risk Swing Trade Opportunities Identified - metal.it
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500 - Smartkarma
Published on: 2025-07-29 17:18:40 - metal.it
TNXP: 2Q25 Financial Update and Deep Dive Into TNX-1500… - Yahoo Finance
Published on: 2025-07-29 07:17:10 - metal.it
What are Tonix Pharmaceuticals Holding Corp. company’s key revenue driversBreakthrough financial growth - jammulinksnews.com
What is the risk reward ratio of investing in Tonix Pharmaceuticals Holding Corp. stockDiscover high-impact stocks for your portfolio - jammulinksnews.com
Is Tonix Pharmaceuticals Holding Corp. stock overvalued or undervaluedBuild a portfolio that outperforms consistently - jammulinksnews.com
What makes Tonix Pharmaceuticals Holding Corp. stock price move sharplyHigh-return market picks - jammulinksnews.com
Why Tonix Pharmaceuticals Holding Corp. stock is on top investor watchlistsFree Market Dynamics Reports - metal.it
Published on: 2025-07-26 12:35:26 - metal.it
Tonix Pharmaceuticals Holding Corp. Stock Analysis and ForecastUnprecedented growth rates - PrintWeekIndia
Tonix Pharma’s Unexpected Rise in Stock Value - timothysykes.com
Is TNXP Stock Ready for Takeoff? - StocksToTrade
Is Tonix Pharmaceuticals Holding Corp. a good long term investmentAccelerated profit realization - PrintWeekIndia
What drives Tonix Pharmaceuticals Holding Corp. stock priceHigh-yield market plays - PrintWeekIndia
What analysts say about Tonix Pharmaceuticals Holding Corp. stockFree High-Return Strategy Alerts - PrintWeekIndia
CD40/CD40L Inhibitors Market on Growth Trajectory Driven by Advancements in Autoimmune and Cancer Therapeutics | DelveInsight - The Malaysian Reserve
Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):